We are live on ! Find out more
IBRX icon

ImmunityBio
IBRX

49 hedge funds and large institutions have $17.6M invested in ImmunityBio in 2020 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 13 increasing their positions, 18 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 12

4% more funds holding

Funds holding: 47 → 49 (+2)

0.35% more ownership

Funds ownership: 5.84% → 6.19% (+0.35%)

10% less call options, than puts

Call options by funds: $316K | Put options by funds: $351K

19% less capital invested

Capital invested by funds: $21.8M → $17.6M (-$4.21M)

28% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 18

Holders
49
Holders Change
+2
Holders Change %
+4.26%
% of All Funds
1.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
13
Reduced
18
Closed
12
Calls
$316K
Puts
$351K
Net Calls
-$35K
Net Calls Change
+$180K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.59M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.14M
3
Goldman Sachs
Goldman Sachs
New York
+$403K
4
Morgan Stanley
Morgan Stanley
New York
+$278K
5
Renaissance Technologies
Renaissance Technologies
New York
+$276K

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$633K
2
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$475K
3
CS
Credit Suisse
Switzerland
-$463K
4
BCM
Bridgeway Capital Management
Texas
-$277K
5
OGC
One68 Global Capital
New York
-$230K
Name Holding Trade Value Shares
Change 		Change in
Stake
GCP
26
GSA Capital Partners
United Kingdom
$38K +$65.7K +13,119 New
AGM
27
Alpine Global Management
New York
$32K -$12.1K -2,418 -18%
Victory Capital Management
28
Victory Capital Management
Texas
$32K +$56.3K +11,246 New
Group One Trading
29
Group One Trading
Illinois
$31K -$2.21K -442 -4%
GAG
30
GM Advisory Group
New York
$31K +$53.5K +10,690 New
State Street
31
State Street
Massachusetts
$30K -$17.6K -3,520 -25%
FAAS
32
First Allied Advisory Services
California
$29K -$28K -5,597 -35%
FIA
33
FNY Investment Advisers
New York
$28K +$50.1K +10,000 New
Simplex Trading
34
Simplex Trading
Illinois
$27K -$47.9K -9,560 -50%
UBS Group
35
UBS Group
Switzerland
$16K -$21.3K -4,251 -43%
Wells Fargo
36
Wells Fargo
California
$11K -$381 -76 -2%
CG
37
Cutler Group
California
$11K +$19.5K +3,900 New
Citigroup
38
Citigroup
New York
$8K -$1.21K -241 -8%
WOC
39
West Oak Capital
California
$8K +$13.4K +2,667 New
US Bancorp
40
US Bancorp
Minnesota
$6K +$10K +2,000 New
DWA
41
Dorsey Wright & Associates
California
$5K +$8.35K +1,668 New
Northwestern Mutual Wealth Management
42
Northwestern Mutual Wealth Management
Wisconsin
$3K – – –
Osaic Holdings
43
Osaic Holdings
Arizona
$2K +$3K +598 New
Carson Wealth (CWM LLC)
44
Carson Wealth (CWM LLC)
Nebraska
$1K – – –
SFS
45
Sowell Financial Services
Arkansas
$1K +$2.5K +500 +5,000%
BNP Paribas Financial Markets
46
BNP Paribas Financial Markets
France
$242 -$756 -151 -64%
OGC
47
One68 Global Capital
New York
– -$230K -60,776 Closed
6CM
48
683 Capital Management
New York
– -$223K -58,748 Closed
Bank of Montreal
49
Bank of Montreal
Ontario, Canada
– -$115K -30,300 Closed
LCM
50
Laurion Capital Management
New York
– -$65K -17,200 Closed
1
2
3

IBRX Hedge Fund Activity: Q1 2020 in Review

49 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in ImmunityBio (IBRX) for Q1 2020, worth a combined $17.6M — down 19% from $21.8M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new IBRX positions and 12 closed out — a net gain of 3 holders — while 13 added to existing stakes and 18 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.59M. The largest seller was JP Morgan Chase, cutting an estimated $633K.

  • 49 institutional investors held ImmunityBio (IBRX) as of Q1 2020, up from 47 in Q4 2019.
  • Funds reported $17.6M of ImmunityBio stock for Q1 2020, down 19% quarter-over-quarter.
  • 15 funds opened new ImmunityBio positions in Q1 2020 and 12 closed out, a net change of +3 holders.
  • The largest ImmunityBio buyer in Q1 2020 was Vanguard Group, an estimated $1.59M added.
  • The largest ImmunityBio seller in Q1 2020 was JP Morgan Chase, an estimated $633K sold.

Based on aggregated 13F filings for Q1 2020.